Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
563,000
-
Total 13F shares
-
86,958
-
Share change
-
-16,853
-
Total reported value
-
$97,000
-
Price per share
-
$1.12
-
Number of holders
-
6
-
Value change
-
-$87,298
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of Bluejay Diagnostics, Inc. - Common Stock (BJDX) as of Q1 2022
As of 31 Mar 2022,
Bluejay Diagnostics, Inc. - Common Stock (BJDX) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,958 shares.
The largest 6 holders included
PERKINS CAPITAL MANAGEMENT INC, BlackRock Inc., JANE STREET GROUP, LLC, Verition Fund Management LLC, Tower Research Capital LLC (TRC), and UBS Group AG.
This page lists
6
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.